Curcumin and its analogues: Potential anticancer agents

Medicinal Research Reviews

Volumn 30, Issue 5, 2010, Pages 818-860

  Agrawal, Dinesh Kumar ^a   Mishra, Pushpesh Kumar ^b  

^a Department of Pharmacy   (India)

^b Sanjay College of Pharmacy   (India)

Author keywords

Anticancer; Curcumin; Diferuloylmethane; Natural product; Synthetic analogues; Turmeric

Indexed keywords

2 HYDROXY NAPHTHYL CURCUMIN; ALLYL CURCUMIN; ANGIOGENESIS INHIBITOR; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIANDROGEN; ANTIMALARIAL AGENT; ANTIMUTAGENIC AGENT; ANTINEOPLASTIC AGENT; ARACHIDONATE 5 LIPOXYGENASE; BENZOTHIAZOLE DERIVATIVE; CASPASE; CINNAMYL CURCUMIN; CURCUMIN; CURCUMIN DERIVATIVE; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GENE PRODUCT; HEXAHYDROCURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; INTERLEUKIN 6; OCTAHYDROCURCUMIN; PIPERONYL CURCUMIN; TETRAHYDROCURCUMIN; TOCOPHERYL CURCUMIN; TRANSCRIPTION FACTOR AP 1; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIBACTERIAL ACTIVITY; ANTIMALARIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; CANCER CELL CULTURE; CANCER MODEL; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; ENZYME ACTIVATION; HUMAN; INFLAMMATION; NONHUMAN; PHYTOCHEMISTRY; PLANT ROOT; REVIEW; RHIZOME; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CURCUMIN; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77957191467     PISSN: 01986325     EISSN: 10981128     Source Type: Journal    
DOI: 10.1002/med.20188     Document Type: Review

References (92)

1. Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991;57:1-7.
2. Kiuchi F, Goto Y, Sugimoto N, Akao N, Kondo K. Nematocidal activity of turmeric: Synergistic action of curcuminopids. Chem Pharm Bull 1993;41:1640-1643.
3. Joe B, Vijaykumar M, Lokesh BR. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit Rev Food Sci & Nutrition 2004;44:97-111.
4. Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: Preclinical and clinical studies. Anticancer Res 2003;23:363-398.
5. Jayaprakash GK, Rao LJ, Sakariah KK. Chemistry and biological activities of Curcuma longa. Trends in Food Sci Tech 2005;16:533.
6. Goel A, Kunnumakkara AB, Aggarwal BB. Curcumin as "curecumin": From kitchen to clinic. Biochem Pharmacol 2008;75:787-809.
7. Anand P, Thomas SG, Kunnumakkara AB, Sundaram C, Harikumar KB, Sung B, Tharakan ST, Misra K, Priyadarsini IK, Rajasekharan KN, Aggarwal BB. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 2008;76:1590-1611.
8. Agrawal DK, Saikia D, Tiwari R, Ojha S, Shanker K, Kumar JK, Gupta AK, Tandon S, Negi AS, Khanuja SPS. Demethoxycurcumin and its semisynthetic analogues as antitubercular Agents. Planta Med 2008;74:1828-1831.
9. Milobedzka I, Kostanecki S, Lamps V. Curcumin. Chem Ber 1910;43:2163-2170.
10. Payton F, Sandusky P, Alworth WL. NMR study of the solution structure of curcumin. J Nat Prod 2007;70:143-146.
11. Pabon HHJ. A synthesis of curcumin and related compounds. Recl Trav Chim Pays-Bas 1964;83:379-386.
12. Babu KVD, Rajasekaran KN. Simplified conditions for the synthesis of curcumin 1 and other curcuminoids. Org Prep Proc Int (0PPI brief) 1994;26:674-677.
13. Soudamini KK, Kuttan R. Inhibition of chemical carcinogenesis by curcumin. J Ethnopharmacol 1989;27:227-233.
14. Anand P, Sundaram C, Jhurani S, Kunnumakkara AB, Aggarwal BB. Curcumin and cancer: An "old-age" disease with an "age-old" solution. Cancer Lett 2008;267:133-164.
15. Leu TH, Maa MC. The molecular mechanisms for the antitumorigenic effect of curcumin. Curr Med Chem-Anti-Cancer Agents 2002;2:357-370.
16. Deshpande SS, Maru GB. Effects of curcumin on the formation of benzo[a]pyrene derived DNA adducts in vitro. Cancer Lett 1995;96:71-80.
17. Huang MT, Ma W, Lu YP, Chang RL, Fisher C, Manchand PS, Newmark HI, Conney AH. Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12- O-tetradecanoylphorbol-13-acetate- induced tumor promotion. Carcinogenesis 1995;16:2493-2497.
18. Lin JK, Chen Y C, Huang YT, Lin SY. Mechanism of cancer chemoprevention by curcumin. J Cell Biochem Suppl 1997;28-29:39-48.
19. Lin LI, Ke YF, Ko YC, Lin JK. Curcumin inhibits SK-Hep-I hepatocellular carcinoma cell invasion in vitro and suppresses matrix metalloproteinase-9 secretion. Oncology 1998;55:349-353.
20. Oda Y. Inhibitory effect of curcumin on SOS functions induced by UV irradiation. Mutat Res 1995;348:67-73.
21. Kortula L, Cheung JY, Mendelsohn J, Kumar R. Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by curcumin. Carcinogenesis 1995;16:1741.
22. Huang MT, Smart RC, Wong CQ, Conney AH. Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1988;48:5941-5946.
23. Huang MT, Wang ZY, Georgiadis CA, Laskin JD, Conney AH. Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12dimethylbenz[a]anthracene. Carcinogenesis 1992;13:2183-2186.
24. Huang MT, Lou YR, Ma W, Newmark H, Reuhl K, Conney AH. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 1994;54:5841-5847.
25. Tanaka T, Makita H, Ohnishi M, Hirose Y, Wang A, Mori, H, Satoh K, Hara A, Ogawa H. Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: Comparison with the protective effect of betacarotene. Cancer Res 1994;54:4653-4659.
26. Chuang SE, Kuo ML, Hsu CH, Chen CR, Lin JK, Lai GM, Hsieh CY, Cheng AL. Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 2000;21:331-335.
27. Huang MT, Newmark HL, Frenkel K. Inhibitory effects of curcumin on tumorigenesis in mice. J Cell Biochem Suppl 1997;27:26-34.
28. Singletary K, Macdonald C, Walling M, Fisher C. Inhibition of 7, 12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett 1996;103:137-141.
29. Chen HW, Huang HC. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Brit J Pharmacol 1998;124:1029-1040.
30. Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 2005;70:700-713.
31. Opletalova V. Constituents of the plants of the Zingiberaceae family and their synthetic analogs as potential anti-inflammatory agents. Ceska Slov Farm 1995;44:305-307.
32. Chun KS, Park KK, Lee J, Kang M, Surh YJ. Inhibition of mouse skin tumor promotion by antiinflammatory diarylheptanoids derived from Alpinia oxyphylla Miquel (Zingiberaceae). Oncology Res 2002;13:37-45.
33. Park SY, Kim DSHL. Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: A drug discovery effort against Alzheimer's disease. J Nat Prod 2002;65:1227-1231.
34. Dutta S, Murugkar A, Gandhe N, Padhye S. Enhanced antioxidant activities of metal conjugates of curcumin derivatives. Metal Based Drugs 2001;8:183-187.
35. Dutta S, Padhye S, Priyadarsini KI, Newton C. Antioxidant and antiproliferative activity of curcumin semicarbazone. Bioorg Med Chem Lett 2005;15:2738-2744.
36. Shim JS, Kim DH, Jung HJ, Kim JH, Lim D, Lee SK, Kim KW, Ahn JW, Yoo JS, Rho JR, Shin J, Kwon HJ. Hydrazinocurcumin, a novel synthetic curcumin derivative is a potent inhibitor of endothelial cell proliferation. Bioorg Med Chem 2002:10:2987-2992. (Pubitemid 34761878)
37. Mishra S, Kapoor N, Ali A, Pardhasaradhi B, Kumari AL, Khar A, Misra K. Differential apoptotic and redox regulatory activity of curcumin and its derivatives. Free Radic Bio Med 2005;38:1353-1360.
38. Mishra S, Karmodiya K, Suroli N, Surolia A. Synthesis and exploration of novel curcumin analogues as anti-malarial agents. Bioorgan Med Chem 2008;16:2894-2902.
39. Simoni D, Rizzi M, Rondanin R, Baruchello R, Marchetti P, Invidiata FP, Labbozzetta M, Poma P, Carina V, Notarbartolo M, Alaimoc A, Alessandro ND. Antitumor effects of curcumin and structurally b-diketone modified analogs on multidrug resistant cancer cells. Bioorg Med Chem Lett 2008;18:845-849.
40. Flynn DL, Belliotti TP, Boctor AM, Connor DT, Kostlan CR, Nies DE, Ortwine DF, Schrier DJ, Sircar JC. Styrylpyrazoles, styryisoxazoles and styrylisothiazoles. Novel 5-lipoxygenase and cyclooxygenase inhibitors. J Med Chem 1991;34:518-525.
41. Anto RJ, George J, Babu KVD, Rajasekharan KN, Kuttan R. Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. Mutat Res 1996;370:127-131. (Pubitemid 26343824)
42. Mazumder A, Neamati N, Sunder S, Schulz J, Pertz H, Eich E, Pommier Y. Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action. J Med Chem 1997;40:3057-3063.
43. Sardjiman SS, Reksohadiprodjo MS, Hakim L, Goot H, Timmerman H. Diphenyl-1, 4-pentadiene-3-ones and cyclic analogues as antioxidative agents. Synthesis and structure-activity relationship. Eur J Med Chem 1997;32:625-630.
44. Nurfina AN, Reksohadiprodjo MS, Timmerman H, Jenie UA, Sugiyanto D, van der Goot H. Synthesis of some symmetrical curcumin derivatives and their antiinflammatory activity. Eur J Med Chem 1997;32:321-328.
45. Nurrochmad A, Supardjan AM. Sardjiman: Inhibition of cyclooxygenase by cyclovalone and its three analogue compounds. Majalah Farmasi Indonesia 1998;9:180-185.
46. Barthelemy S, Vergnes L, Moynier M, Guyot D, Labidalle S, Bahraoui E. Curcumin and curcumin derivatives inhibit Tat-mediated transactivation of type-1 human immunodeficiency virus long terminal repeat. Research Vir 1998;149:43.
47. Venkatesan P, Rao MNA. Structure-activity relationships for the inhibition of lipid peroxidation and the scavenging of free radicals by synthetic symmetrical curcumin analogues. J Pharm Pharmacol 2000;52:1123-1128.
48. Ohtsu H, Xiao Z, Ishida J, Nagai M, Wang H, Itokawa HS, Shih C, Chiang T, Chang E, Lee Y, Tsai M, Chang C, Lee K. Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as antiprostate cancer agents. J Med Chem 2002;45:5037-5042.
49. Ohtsu H, Itokawa H, Xiao Z, Su CY, Shih CCY, Chiang T, Chang E, Lee YF, Chiu SY, Chang C, Lee KH. Antitumor agents 222. Synthesis and anti-androgen activity of new diarylheptanoids. Bioorg Med Chem 2003;11:5083-5090.
50. Ishida J, Ohtsu H, Tachibana Y, Nakanishi Y, Bastow KF, Nagai M, Wang H, Itokawa H, Lee K. Antitumor agents. Part 214: Synthesis and evaluation of curcumin analogues as cytotoxic agents. Bioorg Med Chem 2002;10:3481-3487.
51. Hahm ER, Cheon G, Lee J, Kim B, Park C, Yang CH. New and known symmetrical curcumin derivatives inhibit the formation of Fos-Jun-DNA complex. Cancer Lett 2002;184:89-96.
52. Hahm ER, Gho YS, Park S, Park C, Kim KW, Yang CH. Synthetic curcumin analogues inhibit activator protein-1 transcription and tumor-induced angiogenesis. Biochem Biophys Res Commun 2004;321:337-344. (Pubitemid 39055751)
53. John VD, Kuttan G, Krishnankutty K. Antitumor studies of metal chelates of synthetic curcuminoids. J Exp Clin Canc Res 2002;2:219-224.
54. Dimmock JR, Jha A, Zello GA, Quail JW, Oloo EO, Nienaber KH, Kowalczyk ES, Allen TM, Santos CL, Clercq ED, Balzarini J, Manavathu EK, Stables JM. Cytotoxic N-[4-(3-aryl-3-oxo-1-propenyl) phenylcarbonyl]-3, 5-bis (phenylmethylene)-4-piperidones and related compounds. European Journal of Medicinal Chemistry 2002;37:961-972.
55. Dimmock JR, Padmanilayam MP, Puthucode RN, Nazarali AJ, Motaganahalli NL, Zello GA, Quail JW, Oloo EO, Kraatz HB, Prisciak JS, Allen, TM, Santos CL, Balzarini J, Clercq ED, Manavathu EK. A conformational and structure activity relationship study of cytotoxic 3,5-bis(arylidene)-4-piperidones and related N-acryloyl analogues. J Med Chem 2001;44:586-593.
56. Devasena T, Rajasekaran KN, Gunasekaran G, Viswanathan P, Menon VP. Anticarcinogenic effect of bis-1,7-(2-hydroxyphenyl)-hepta-1, 6-diene-3, 5-dione a curcumin analog on DMH-induced colon cancer model. Pharmacol Res 2003;47:133-140.
57. Robinson TP, Ehlers T, Hubbard RB, IV, Bai X, Arbiser JL, Goldsmith DJ, Bowen JP. Design, synthesis and biological evaluation of angiogenesis inhibitors: Aromatic enones and dienone analogues of curcumin. Bioorg Med Chem 2003;13:115-117.
58. Robinson TP, Hubbard RB, IV, Ehlers TJ, Arbiser JL, Goldsmithd DJ, Bowena JP. Synthesis and biological evaluation of aromatic enones related to Curcumin. Bioorg Med Chem 2005;13:4007-4013.
59. Ligeret H, Barthelemy S, Zini R, Tillement JP, Labidalle S, Morin D. Effects of curcumin and curcumin derivatives on mitochondrial permeability transition pores. Free Radic Bio Med 2004;36:919-929.
60. Adams BK, Ferstl EM, Davis MC, Herold M, Kurtkaya S, Camalier RF, Hollingshead MG, Kaur G, Sausville EA, Rickles FR, Snyder JP, Liotta DC, Shoji M. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. Bioorg Med Chem 2004;12:3871-3883.
61. Ahn CM, Shin W, Woo HB, Lee S, Lee H. Synthesis of symmetrical bis-alkynyl or alkyl pyridine and thiophene derivatives and their antiangiogenic activities. Bioorg Med Chem Lett 2004;14:3893-3896.
62. Gafner S, Lee SK, Cuendet M, Barthelemy S, Vergnes L, Labidalle S, Mehta RG, Boone CW, Pezzuto JM. Biologic evaluation of curcumin and structural derivatives in cancer chemoprevention model systems. Phytochemistry 2004;65:2849-2859.
63. Youssef KM, Sherbeny MAE, Shafie FSE, Farag HA, Deeb OAA, Awadalla SAA. Synthesis of curcumin analogues as potential antioxidant. Cancer Chemopreventive Agents. Arch Pharm Med Chem 2004;337:42-54.
64. Youssef KM, Sherbeny MAE. Synthesis and antitumor activity of some curcumin analogs. Arch Pharm Chem Life Sci 2005;338:181-189.
65. Park CH, Lee JH, Yang CH. Curcumin derivatives inhibit the formation of Jun-Fos-DNA complex independently of their conserved cysteine residues. J Biochem Mol Bio 2005;38:474-480.
66. Woo HB, Shin WS, Leed S, Ahna CM. Synthesis of novel curcumin mimics with asymmetrical units and their anti-angiogenic activity. Bioorg Med Chem Lett 2005;15:3782-3786.
67. Venkateswarlu S, Ramachandra MS, Subbaraju GV. Synthesis and biological evaluation of polyhydroxycurcuminoids. Bioorg Med Chem 2005;13:6374-6380.
68. Sun A, Shoji M, Lu YJ, Liotta DC, Snyder JP. Synthesis of EF24-tripeptide chloromethyl ketone: A novel curcumin-related anticancer drug delivery system. J Med Chem 2006;49:3153-3158.
69. Lozada MC, Avila EV, Montiel JL, Villarreal ML, Enriquez RG, Gnecco D. P-091, Synthesis and biological activity of a new benzothiazol derivative of curcumin. Planta med 2006;72:961-1089.
70. Weber WM, Hunsaker LA, Roybal CN, Marjon EVB, Abcouwer SF, Royer RE, Decka LM, Jagtb DLV. Activation of NFêB is inhibited by curcumin and related enones. Bioorg Med Chem 2006;14:2450-2461.
71. Weber WM, Hunsaker LA, Gonzales AM, Heynekamp JJ, Orlando RA, Deck LM, Jagt DLV. TPA-induced up-regulation of activator protein-1 can be inhibited or enhanced by analogs of the natural product curcumin. Biochem Pharmacol 2006;72:928-940.
72. Jankun J, Aleem AM, Malgorzewicz S, Szkudlarek M, Zavodszky MI, Witt DLD, Feig M, Selman SH, Jankun ES. Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells. Mol Cancer Ther 2006;5:1371-1382.
73. Deng SL, Chen WF, Zhou B, Yang L, Liu ZL. Protective effects of curcumin and its analogues against free radical-induced oxidative haemolysis of human red blood cells. Food Chem 2006;98:112-119.
74. Ohori H, Yamakoshi H, Tomizawa M, Shibuva M, Kakudo Y, Takahashi A, Takahashi S, Kato S, Suzuki T, Ishioka C, Iwabuchi Y, Shibata H. Synthesis and biological analysis of new curcumin analogues bearing an enhanced potential for the medicinal treatment of cancer. Mol Cancer Ther 2006;5:2563-2570.
75. Chen WF, Deng SL, Zhou B, Yang L, Liu ZL. Curcumin and its analogues as potent inhibitors of low density lipoprotein oxidation: H- atom abstraction from the phenolic groups and possible involvement of the 4-hydroxy-3-methoxyphenyl groups. Free Radic Biol Med 2006;40:526-535.
76. Du Z, Liu R, Shao W, Mao X, Ma L, Gu L, Huang Z, Chan ASC. a-Glucosidase inhibition of natural curcuminoids and curcumin analogues. Eur J Med Chem 2006;41:213-218.
77. Wei QY, Chen WF, Zhou B, Yang L, Liu ZL. Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues. Biochim Biophys Acta 2006;1780:70-77.
78. Lin L, Shi Q, Nyarko AK, Bastow KF, Wu CC, Su CY, Shih CCY, Lee KH. Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents. J Med Chem 2006;49:3963-3972.
79. Lin L, Shi Q, Su C, Shih C, Lee K. Antitumor agents 247. New 4-etoxycarbonylethyl curcumin analogues as potential antiandrogenic agents. Bioorg Med Chem 2006;14:2527-2534.
80. Dubey SK, Sharma AK, Narain U, Misra K, Pati U. Design, synthesis and characterization of some bioactive conjugates of curcumin with glycine, glutamic acid, valine and demethylenated piperic acid and study of their antimicrobial and antiproliferative properties. Eur J Med Chem 2008;43:1837-1846.
81. Kalpana C, Sudheer AR, Rajasekharan KN, Menon VP. Comparative effects of curcumin and its synthetic analogue on tissue lipid peroxidation and antioxidant status during nicotine-induced toxicity. Singapore Med J 2007;48:124-130.
82. Youssef D, Nichols CE, Cameron TS, Balzarini J, Clercqd ED, Jhab A. Design, synthesis, and cytostatic activity of novel cyclic curcumin analogues. Bioorg Med Chem Lett, 2007;17:5624-5629.
83. Safavy A, Raisch KP, Mantena S, Sanford LL, Sham SW, Krishna NR, Bonner JA. Design and development of water-soluble curcumin conjugates as potential anticancer agents. J Med Chem 2007;50:6284-6288.
84. Chandru H, Sharada AC, Bettadaiah BK, Kumar CSA, Rangappa KS, Jayashree K. In vivo growth inhibitory and anti-angiogenic effects of synthetic novel dienone cyclopropoxy curcumin analogs on mouse Ehrlich ascites tumor. Bioorg Med Chem 2007;15:7696-7703.
85. Somparn P, Phisalaphong C, Nakornchai S, Unchern S, Morales NP. Comparative antioxidant activities of curcumin and its demethoxy and hydrogenated derivatives. Biol Pharm Bull 2007;30:74-78.
86. Handler N, Jaeger W, Puschacher H, Leisser K, Erker T. Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitors. Chem Pharm Bull 2007;55:64-71.
87. Zhang Q, Fu Y, Wang HW, Gong T, Qin Y, Zhang ZR. Synthesis and cytotoxic activity of novel curcumin analogues. Chin Chem Lett 2008;19:281-285.
88. Shishu, Kaur IP. Antimutagenicity of curcumin and related compounds against genotoxic heterocyclic amines from cooked food: The structural requirement. Food Chem 2008;111:573-579.
89. Selvendiran K, Tong L, Vishwanath S, Bratasz A, Trigg NJ, Kutala VK, Hideg K, Kuppusamy P. EF24 induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by increasing PTEN expression. J Biol Chem 2007;282:28609-28618. (Pubitemid 47606012)
90. Liang G, Yang S, Jiang Y, Zhao L, Shao J, Xiao F, Ye Y, Li X. Synthesis and anti-bacterial properties of mono-carbonyl analogues of curcumin. Chem Pharm Bull 2008;56:162-167. (Pubitemid 351206638)
91. Liang G, Li X, Chen L, Yang S, Wu X, Studer E, Gurley E, Hylemon PB, Ye F, Lid Y, Zhou H. Synthesis and anti-inflammatory activities of mono-carbonyl analogues of curcumin. Bioorg Med Chem Lett 2008;18:1525-1529. (Pubitemid 351226515)
92. Liang G, Yang S, Zhou H, Shao L, Huang K, Xiao J, Huang Z, Li X. Synthesis, crystal structure and anti-inflammatory properties of curcumin analogues. Eur J Med Chem 2008;44:915-919.